Keywords: Gilead Sciences, Elvitegravir, Cobicistat, HIV infection, USA, FDA, Call for price restrant, AHF

Gilead files elvitegravir and cobicistat with FDA; AHF plea on Quad pricing

Article | 29 June 2012

Print This

US biotech firm Gilead Sciences (Nasdaq: GILD), world’s largest maker of HIV drugs, has submitted a New Drug ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in